FINNENCE ▪ THE WIRE FILE
THE WIRE · № 76901
News■ Unclear/unknown
Doximity and U.S. News & World Report Extend Partnership to Connect Patients with Hospitals and Doctors
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A partnership extension expands Doximity's referral reach but discloses no financial terms.
Incremental healthcare platform partnership, no numbers
CATALYST TO WATCH
Monetization details or subscriber growth
MAIN RISK
No disclosed economics to underwrite
FULL DISPATCH
Doximity helps to power U.S. News' Doctor Finder, Patient Connect appointment booking tools used by over 65 million Americans annually to find and schedule care SAN FRANCISCO and WASHINGTON, Oct. 13, 2026 /PRNewswire/ -- Doximity (NYSE: DOCS), the leading digital platform for U.S. medical...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
←CORRELATIONshares Healthcare
Gottlieb on how AI is assisting in the development of cancer vaccines2026-10-12 19:00 UTC
Gottlieb on how AI is assisting in the development of cancer vaccines2026-10-12 19:00 UTC
←CORRELATIONshares Healthcare
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged2026-10-12 20:10 UTC
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged2026-10-12 20:10 UTC
←CORRELATIONshares Healthcare
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care2026-10-12 20:25 UTC
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care2026-10-12 20:25 UTC
←CORRELATIONshares Healthcare
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
←CORRELATIONshares Healthcare
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight2026-10-12 20:58 UTC
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight2026-10-12 20:58 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.